Yang Yafan, Wang Guiying, He Jingli, Wu Fengpeng, Ren Shuguang
Department of General Surgery, Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, China.
Animal Center, Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, China.
J Cancer Res Clin Oncol. 2017 Jan;143(1):105-114. doi: 10.1007/s00432-016-2240-2. Epub 2016 Sep 20.
Robotic gastrectomy (RG) has been developed to improve surgical quality and to overcome the limitations of conventional open gastrectomy (OG) for gastric cancer. The aim of this meta-analysis is to comprehensively compare the safety and efficacy between robotic surgery and open surgery for treating gastric cancer.
Major databases were searched for retrospective case-matched studies comparing RG and OG for treating gastric cancer. A list of these studies, published in English from 1990 to 2016, was obtained independently by two reviewers from databases such as PubMed, MEDLINE, ScienceDirect, the China National Knowledge Infrastructure and Web of Science. Intraoperative data, oncological outcomes and postoperative complications were compared using Review Manager 5.3.
Seven studies involving 5970 patients with 606 cases of RG and 5364 cases of OG were included in this meta-analysis. Compared to OG, RG has a significantly longer operation time [weighted mean differences (WMD) = 63.72, 95 % confidence interval (CI) 33.83-93.61, P < 0.0001], lower blood loss (WMD: -129.74, 95 % CI -178.31 to -81.16, P < 0.00001) and shorter hospital stay (WMD = -2.39, 95 % CI -2.92 to -1.87; P < 0.00001). No statistical difference was noted based on the rate of overall postoperative complication, wound infection, bleeding, ileus and obstruction, abdominal collections and abscesses, and the rate of anastomotic leak in the RG versus OG. Postoperative oncological outcomes showed that there were also no statistical differences among the number of retrieved lymph nodes, proximal resection margin, distal resection margin except for tumor size (WMD = -1.60; 95 % CI -2.96 to -0.25; P = 0.02).
The results of this meta-analysis suggest that RG will be more accessible than conventional OG for gastric cancer. However, more prospective, well-designed, multicenter, randomized controlled trials are necessary to further evaluate the safety and efficacy as well as the long-term outcome of this technology.
机器人胃癌切除术(RG)已被研发出来,以提高手术质量并克服传统开放胃癌切除术(OG)的局限性。本荟萃分析的目的是全面比较机器人手术和开放手术治疗胃癌的安全性和有效性。
检索主要数据库,查找比较RG和OG治疗胃癌的回顾性病例对照研究。两名评审员分别从PubMed、MEDLINE、ScienceDirect、中国知网和科学引文索引等数据库独立获取了1990年至2016年以英文发表的这些研究列表。使用Review Manager 5.3比较术中数据、肿瘤学结局和术后并发症。
本荟萃分析纳入了7项研究,共5970例患者,其中606例接受RG,5364例接受OG。与OG相比,RG的手术时间显著更长[加权平均差(WMD)=63.72,95%置信区间(CI)33.83 - 93.61,P<0.0001],失血量更低(WMD:-129.74,95%CI -178.31至-81.16,P<0.00001),住院时间更短(WMD=-2.39,95%CI -2.92至-1.87;P<0.00001)。在RG与OG之间,总体术后并发症、伤口感染、出血、肠梗阻、腹部积液和脓肿以及吻合口漏的发生率方面未发现统计学差异。术后肿瘤学结局显示,除肿瘤大小外(WMD=-1.60;95%CI -2.96至-0.25;P=0.02),在获取的淋巴结数量、近端切缘、远端切缘方面也无统计学差异。
本荟萃分析结果表明,对于胃癌,RG比传统OG更具优势。然而,需要更多前瞻性、设计良好、多中心、随机对照试验来进一步评估该技术的安全性和有效性以及长期结局。